Drug Research
I-Mab Announces Multiple Advancements of 4-1BB Bispecific Antibody Portfolio
I-Mab, a clinical-stage biopharmaceutical company committed to the discovery, development, and commercialization of novel biologics, announced multiple advancements in its 4-1BB bispecific antibody portfolio....
Drug Research
Batavia to develop innovative clinical process for RocketVax’s second generation COVID-19 vaccine
Batavia Biosciences announces their collaboration with RocketVax, a subsidiary of Swiss Rockets AG developing vaccines based on breakthrough genetic engineering. Under the agreement, Batavia...
Drug Research
I-Mab Expands Emerging Portfolio of Next Generation Novel Oncology Therapeutics Through Cutting-Edge mRNA and AI Technology Platforms
I-Mab, a clinical stage biopharmaceutical company committed to the discovery, development and commercialization of novel biologics, announced the signing of two new collaborations with...
Drug Research
Vaxart Announces Exclusive Worldwide License Agreement with Altesa Biosciences for its Vapendavir Antiviral Asset
Vaxart, Inc., a clinical-stage biotechnology company developing oral recombinant vaccines that are administered by tablet rather than by injection, announced that it has signed...
News
New Analysis Supports Medisafe’s Impact on Medication Persistence, Adherence
Medisafe, a leading digital drug companion company, announced the findings from two validation studies examining the impact of its digital drug companion on persistence...
Clinical Trials
UPS Healthcare Partners with THREAD to Deliver First Decentralized Clinical Trial Platform
UPS Healthcare's clinical trial logistics unit, Marken, and THREAD, an innovative decentralized clinical trial technology provider, announced a partnership to bring the first ever,...
Drug Research
Oxford researchers launch HIV vaccine trial
The University of Oxford has launched a Phase I trial of a novel mosaic vaccine targeting a ‘broad range’ of HIV variants.
The HIV-CORE 0052...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read